Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Letters

• Publication date

  2001-12-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0304-3835(01)00690-5PMID 11689286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome.

  2005cited by this paper
• Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.

  2000cited by this paper
• Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome.

  2000cited by this paper
• Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues.

  2000cited by this paper
• Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers.

  2000cited by this paper
• Molecular mechanism of nucleotide excision repair.

  1999cited by this paper
• Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer.

  1999cited by this paper
• Three distinct regions of allelic loss at 13q14, 13q21‐22, and 13q33 in prostate cancer

  1999cited by this paper
• Role of FHIT in human cancer.

  1999cited by this paper
• Quality control by DNA repair.

  1999cited by this paper
• Role of FHIT in Human Cancer

  1999cited by this paper
• Loss of heterozygosity in human ovarian cancer on chromosome 19q.

  1997cited by this paper
• Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome

  1997cited by this paper
• Enhanced XPA mRNA levels in cisplatin-resistant human ovarian cancer are not associated with XPA mutations or gene amplification.

  1996cited by this paper
• A constitutional bws‐related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in wilms' tumors

  1995cited by this paper
• Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis

  1995cited by this paper
• Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues.

  1994cited by this paper
• Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma.

  1994cited by this paper
• Inactivation of both APC alleles in human and mouse tumors.

  1994cited by this paper
• Microsatellite instability in bladder cancer.

  1993cited by this paper
• Microsatellite instability in cancer of the proximal colon.

  1993cited by this paper
• Multiple forms of the APC gene transcripts and their tissue-specific expression.

  1993cited by this paper
• Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay.

  1993cited by this paper
• Role of chromosome 9 in human bladder cancer.

  1993cited by this paper
• Hypermutability and mismatch repair deficiency in RER+ tumor cells.

  1993cited by this paper
• Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines

  1992cited by this paper
• ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients.

  1992cited by this paper
• Proliferating cell nuclear antigen is required for DNA excision repair.

  1992cited by this paper
• Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer

  1992cited by this paper
• The Metabolic basis of inherited disease

  1989cited by this paper

• Comprehensive genetic and epigenetic characterization of Lynch‐like syndrome patients

  2025influential citation
• Significance and implications of FHIT gene expression and promoter hypermethylation in acute lymphoblastic leukemia (ALL)

  2024cites this paper
• Modulation of Cytotoxicity by Transcription-Coupled Nucleotide Excision Repair Is Independent of the Requirement for Bioactivation of Acylfulvene.

  2017cites this paper
• Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance

  2017influential citation
• Cadernos de Anatomia Patológica Pathology Notebooks

  2016cites this paper
• XPC codon 939 polymorphism is associated with susceptibility to DNA damage induced by aflatoxin B1 exposure.

  2015cites this paper
• Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer

  2015cites this paper
• Synthetic Nucleobases and Small Molecules as Mechanistic Probes for DNA Repair

  2015cites this paper
• Tumor and Stem Cell Biology DDB 2 Suppresses Epithelial-to-Mesenchymal Transition in Colon Cancer

  2013cites this paper
• DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

  2013cites this paper
• Oxaliplatine : ERCC et glutathion S-transférases

  2013cites this paper
• The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cells.

  2012cites this paper
• Deficiency of DNA repair nuclease ERCC1‐XPF promotes prostate cancer progression in a tissue recombination model

  2012cites this paper
• Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (XPC) expression in sporadic breast cancer patients

  2012cites this paper
• Chemistry and biology of acylfulvenes: sesquiterpene-derived antitumor agents.

  2012cites this paper
• A molecular signature for oncogenic BRAF in human colon cancer cells is revealed by microarray analysis.

  2012cites this paper
• Role of DNA Repair Gene Polymorphisms in the Efficiency of Platinum-Based Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

  2011cites this paper
• In vitro functional effects of XPC gene rare variants from bladder cancer patients

  2011cites this paper
• Role of DNA repair gene polymorphisms in the efficiency of platinum-based adjuvant chemotherapy for non-small cell lung cancer.

  2011cites this paper
• Nucleotide Excision repair pathway modulating both cancer risk and therapy

  2010cites this paper
• The effect of oxidative stress on nucleotide-excision repair in colon tissue of newborn piglets.

  2010cites this paper
• Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1–related hepatocellular carcinoma in the Guangxi population

  2010influential citation
• Expression of Xeroderma Pigmentosum Group G (XPG) in Sporadic Breast Carcinoma

  2010cites this paper
• Os genes ERCC1 e RRM1 no carcinoma broncopulmonar

  2009cites this paper
• Micronuclei and chromosomal aberrations, important markers of ageing: possible association with XPC and XPD polymorphisms.

  2009cites this paper
• [ERCC1 and RRM1 genes in lung cancer].

  2009cites this paper
• Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: Pathological significance in early- and late-onset breast carcinoma

  2008cites this paper
• Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers

  2008cites this paper
• XPC genotypes/diplotypes play no independent or interaction role with PAH-DNA adducts for breast cancer risk

  2008cites this paper
• ERCC5 is a novel biomarker of ovarian cancer prognosis.

  2008cites this paper
• Associations between XPC polymorphisms and risk of cancers: A meta-analysis.

  2008cites this paper
• DNA Repair Modulators as Anticancer Agents

  2008cites this paper
• Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk.

  2008cites this paper
• Impairment of alveolar macrophage transcription in idiopathic pulmonary fibrosis.

  2007cites this paper
• A mathematical model of breast cancer development, local treatment and recurrence.

  2007cites this paper
• The C19007T Polymorphism of ERCC1 and Its Correlation with the Risk of Epithelial Ovarian and Endometrial Cancer in Korean Women

  2007cites this paper
• XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.

  2007cites this paper
• Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity.

  2007cites this paper
• Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer.

  2007cites this paper
• Association of XRCC1 gene polymorphisms with the susceptibility and chromosomal aberration of testicular germ cell tumors.

  2006cites this paper
• The role of XPB in cell apoptosis and viability and its relationship with p53, p21(waf1/cip1) and c-myc in hepatoma cells.

  2006cites this paper
• Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome

  2005cites this paper
• The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular responses

  2005cites this paper
• ERCC1 Codon 118 Polymorphism Is a Predictive Factor for the Tumor Response to Oxaliplatin/5-Fluorouracil Combination Chemotherapy in Patients with Advanced Colorectal Cancer

  2005cites this paper
• Irofulven Cytotoxicity Depends on Transcription-Coupled Nucleotide Excision Repair and Is Correlated with XPG Expression in Solid Tumor Cells

  2004cites this paper
• The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response

  2004cites this paper
• Molecular predictors of response to chemotherapy in lung cancer.

  2004cites this paper
• Pharmacogenetics of neoplastic diseases: new trends.

  2004cites this paper
• Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer.

  2004cites this paper
• The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation.

  2004cites this paper
• Antitumor activity of irofulven monotherapy and in combination with mitoxantrone or docetaxel against human prostate cancer models

  2004cites this paper
• Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers—a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas

  2004cites this paper
• Genetic testing for chemotherapy in non-small cell lung cancer.

  2003cites this paper
• Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis.

  2003cites this paper
• Allelotypes as potential prognostic markers in ovarian carcinoma treated with cisplatin-based chemotherapy.

  2003cites this paper
• BRCA1 and p53: compensatory roles in DNA repair

  2003cites this paper
• Influence of genetic markers on survival in non-small cell lung cancer.

  2003cites this paper
• Nucleotide excision repair rates in rat tissues.

  2003cites this paper
• Loss of heterozygosity analysis of mouse pulmonary adenomas induced by coal tar

  2003cites this paper
• Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients.

  2003cites this paper
• Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer

  2003influential citation
• Laser Literature Watch

  2002cites this paper
• Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer.

  2002cites this paper
• Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action

  2002cites this paper
• Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells.

  2002cites this paper
• Laser literature watch.

  2002cites this paper
• Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells.

  2002cites this paper